SCHEMBL22501751

SCHEMBL22501751

CC1(C)c2ccccc2N(c2cccc3ccccc23)c2ccccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.54
KMT2A Q03164 5/20 0.54
KDM4E B2RXH2 4/20 0.54
MEN1 O00255 3/20 0.54
MAPK1 P28482 2/20 0.54
ELANE P08246 1/20 0.50
GAA P10253 1/20 0.49
POLB P06746 1/20 0.49
ALDH1A1 P00352 5/20 0.48
SMN1; SMN2 Q16637 3/20 0.44
HSD17B10 Q99714 2/20 0.44
HPGD P15428 2/20 0.44
PKM P14618 2/20 0.44
CYP1A2 P05177 2/20 0.40
CYP2D6 P10635 2/20 0.40
NPC1 O15118 1/20 0.40
HTR3E A5X5Y0 1/20 0.40
HTR3B O95264 1/20 0.40
HTR1A P08908 1/20 0.40
NCF1 P14598 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30825127 1.00 MAPT (0.54) MAPTKMT2AKDM4EMEN1MAPK1
SCHEMBL12723294 0.93 MAPT (0.49) MAPTKMT2AKDM4EMEN1MAPK1
SCHEMBL13231590 0.90 KMT2A (0.46) MAPTKMT2AKDM4EMEN1MAPK1
SCHEMBL13557653 0.89 MAPT (0.45) MAPTKMT2AKDM4EMEN1MAPK1
SCHEMBL13557588 0.89 MAPT (0.45) MAPTKMT2AKDM4EMEN1MAPK1
SCHEMBL17804595 0.88 MAPT (0.44) MAPTKMT2AKDM4EMEN1MAPK1
SCHEMBL28623453 0.84 POLB (0.43) MAPTKMT2AKDM4EMEN1MAPK1
SCHEMBL22359126 0.83 MAPT (0.43) MAPTKMT2AKDM4EMEN1MAPK1
SCHEMBL22501427 0.82 ELANE (0.42) MAPTKMT2AKDM4EMEN1MAPK1
SCHEMBL30825104 0.82 ELANE (0.42) MAPTKMT2AKDM4EMEN1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117683019-A Bromination method of 9, 10-dihydroacridine derivative 郑州原理生物科技有限公司 2024-03-12 CN disclosed
US-20220169607-A1 CARBAZOLE AND ACRIDINE PHOTOREDOX CATALYSTS FOR SMALL MOLECULE AND MACROMOLECULAR TRANSFORMATIONS COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2022-06-02 US disclosed
US-20220169607-A1 CARBAZOLE AND ACRIDINE PHOTOREDOX CATALYSTS FOR SMALL MOLECULE AND MACROMOLECULAR TRANSFORMATIONS COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2022-06-02 US disclosed
WO-2020205765-A1 CARBAZOLE AND ACRIDINE PHOTOREDOX CATALYSTS FOR SMALL MOLECULE AND MACROMOLECULAR TRANSFORMATIONS COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2020-10-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220169607-A1 CARBAZOLE AND ACRIDINE PHOTOREDOX CATALYSTS FOR SMALL MOLECULE AND MACROMOLECULAR TRANSFORMATIONS PCNA, PPOX, PARP1 MAPT 1216/4885KMT2A 3165/4885KDM4E 3652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.